期刊文献+

转人α-1,2岩藻糖苷转移酶基因在异种移植中的研究 被引量:6

Human [alpha] (1,2)-fucosyltransferase transgene in xexotransplantation
原文传递
导出
摘要 目的研究转人α1,2岩藻糖苷转移酶基因(HT)在克服超急性排斥反应(HAR)中的作用。方法通过脂质体转染将人HT基因转入猪血管内皮细胞(PIECs)中,利用显微注射建立转HT基因小鼠模型,经流式细胞仪检测转HT基因阳性的PIECs表面抗原及小鼠外周血单核细胞表面抗原的变化。结果转HT基因的PIECs表面的α1,3半乳糖(αGal)比阴性对照下降了50%~60%,H抗原由无表达到44%~78%表达阳性;转HT基因小鼠白细胞表面的αGal比阴性对照下降了63%左右,H抗原阳性表达率为95%以上。结论HT基因在细胞和小鼠体内均有较好的表达,可减少异种抗原与异种抗体的反应,在克服超急性排斥反应中能发挥一定的作用。 Objective To study the role of human [ alpha ] (1, 2 )-fucosyltransferase (hHT)transgene in overcoming hypercute rejection (HAR). Methods The hilT expressing vectors pRc-HT were transferred into pig iliac endothelial cells (PIECs) by lipofectinmine mediated method. Transgenic mice were produced by microinjection. The expression of H antigen and α-Gal antigen in PIECs and peripheral blood mononuclear cells (PBMCs) of mice was detected by flow cytometry (FCM). Results The positive expression rate of H antigen in the transfected PIECs and transgenic murine PBMCs was 40 % to 80 % and 95 % respectively. The expression ofα-Gal wassignificantly lower in transfected PIECs(37.18 % ) and transgenic murine PBMCs (34.81% ) than in normal PIECs (99.91% ) and mormal murine PBMCs (34.81% ) respectively. Conclusion hilT transgene could be expressed in PIECs andtransgenic mice, and decrease the expression of α-Gal antigen, which might play roles in preventing HAR.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2005年第8期1001-1002,共2页 Chinese Journal of Experimental Surgery
基金 天津市科技发展计划项目重点资助项目(043803411)
关键词 转人α-1 2岩藻糖苷转移酶基因 异种移植 急性排斥反应 脂质体 Rejection Antigen, heterologous Gene expression
  • 相关文献

参考文献3

  • 1李胜芝,姚旭东,王广有,马腾骧,张泽,张玥.人CD59重组基因在猪血管内皮细胞中的表达[J].中华实验外科杂志,2004,21(10):1192-1193. 被引量:3
  • 2Costa C,Zhao L,Burton WV,et a1.Expression of the human alpha 1,2 fucosyltransferase in transgenic pigs modifies the cell surface carbonhydrate phenotype and confers resistance to human serum-mediated cytolysis.FASEB J,1999,13:1762-1773.
  • 3Costa C, Zhao L, Burton WV, et al. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.Xenotransplantation, 2002, 9 : 45-57.

二级参考文献5

  • 1Damalsso AP ,Vercelotti GM,Platt JL,et al.Inhibition of complementmediated endothelial cell cytotoxicity by decayaccelerating factor.Transplantation,1991,52:530-533.
  • 2Tom EM,Arnt EF.Xenotransplantation:How to overcome the complement obstacle? Mol Immunol ,1999,36:269-276.
  • 3Johnston PS,Wang MW,Lim SM,et al.Disscorrrdant xenografft rejection in an antibody-free model.Transplantation,1992,54:573-576.
  • 4He Z,She R ,Sumitran-Holgersson S,et al .The in vitro activity and apecificity of human endothelial cell-specific promoter in procine cells .Xenotransplantation,2001,8:202-212.
  • 5Brovimans RA,Wieringen PAM,Van Es LA,et al,Relative role of decay-acclerating factor,membrane cofactor,and CD59 in the protection of human endothelial cells against complement mediated lysis.Eur J Immunol,1992,22:3135-3140.

共引文献2

同被引文献74

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部